Speakers
Michael Michell
Michael Michell is Consultant Radiologist at King's College Hospital, London and South East London Breast Screening Programme and National Breast Screening Training Centre.
He has previously served as Chairman of the National Radiologists Breast Screening QA Committee, Chairman RCR Breast Group (BSBR) and has served on the NHSBSP Advisory Committee. He has had an interest in the evaluation of new technology for breast screening and diagnosis and has led studies over the last 15 years in the application of digital breast tomosynthesis in diagnosis and screening. He is the Chief Investigator of PROSPECTS.
PROSPECTS trial research group.
PROSPECTS is a prospective randomized study of digital breast tomosynthesis (DBT) in breast cancer screening. The aim of the study is to measure the effectiveness and cost of DBT compared to standard 2D mammography and to learn about implications for screening and diagnostic assessment practice. Recruitment is taking place at 8 Trial Sites in England and the target of 70,000 is due to be reached by end March 2025.
Progress with recruitment and timing of analysis and presentation of results will be discussed. Current and future planned work by trial collaborators including reader eye tracking, evaluation of reading with thick slice tomosynthesis and AI, and economic evaluation will described.
Managed and payment processed by: KC Jones conference&events Ltd
Telephone: 01332 227773
Email: bsbr@kc-jones.co.uk